Keryx Biopharmaceuticals Live on Revenue Management Cloud using Model N Express

Model N’s out-of-the-box, SaaS Revenue Management solution delivers fast time-to-value Redwood City, CA – April 9, 2015 – Model N, Inc. (NYSE: MODN), the leading Revenue Management Cloud [...]

keryxmodeln

Model N’s out-of-the-box, SaaS Revenue Management solution delivers fast time-to-value

Redwood City, CA – April 9, 2015 – Model N, Inc. (NYSE: MODN), the leading Revenue Management Cloud solutions provider to the life science and technology industries today announced that Keryx Biopharmaceuticals, Inc., a rapidly growing biopharmaceutical company is live on Model N’s Revenue Management Cloud suite using the Model N Express Implementation methodology.

“We are now managing all of our institutional, purchase-based, channel, and managed care contracts, as well as incentives in a single system — Model N’s new Revenue Management Cloud, using the Express methodology,” said Matt Gray, Executive Director of Financial Planning and Analysis, Keryx Biopharmaceuticals. “Model N Express helps efficiently process our transactions and should drive more accurate and efficient pricing, rebating, and accruals processes with no-hassle upgrades and no requirement to host the software or manage the infrastructure.”

Model N Express enables midmarket life sciences companies of all sizes to maximize revenues and reduce compliance risk with enterprise-grade Revenue Management delivered as a pre-configured, best practices, SaaS solution.

According to a study by KPMG, 32% of midmarket executives report that their most significant barrier to growth is pricing pressure. These organizations however, do not have the resources or time to implement comprehensive Revenue Management solutions that can strategically drive growth by maximizing revenues.

Model N Revenue Management Cloud is a mission-critical enterprise-grade SaaS solution. Model N Express is an out-of-the-box, preconfigured, best practices implementation methodology that is designed for quick time to value at a fixed price. By leveraging Revenue Management Cloud and the Express implementation methodology, Keryx was able to go-live with best practices in contracting, rebating, and channel management within 6 months.

“Midmarket companies require an out-of-the-box, end-to-end Revenue Management solution as the cornerstone of a successful revenue growth strategy in the life science industry” said Zack Rinat,Founder, Chairman and Chief Executive Officer at Model N. “Model N has packaged 14 years of experience working with the largest brands in life sciences — including J&J, Merck, Corning, AstraZeneca, and Stryker — into an enterprise-grade SaaS offering for midmarket companies.”

Resources

•        Model N Express

•        Model N for the Life Sciences

•        Model N Revenue Management

About Model N

Model N is the leader in Revenue Management Cloud solutions. Model N helps its customers maximize their revenues by maximizing sell time, revenues per opportunity and number of opportunities. Model N Cloud solutions manage every dollar that impacts the customer’s top line and transforms the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the unique business needs of life science and technology companies across more than 100 countries. Global customers include: Actavis, Allergan, Atmel, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: http://www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.

Legal

Model N® is a registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

Connect with Model N

LinkedIn

Twitter (@ModelN)

Facebook

Google+

Media Contact

Sara Black

Grayling

Tel: 213.618.1501

Email: sara.black@grayling.com

Model N Global Price Management SaaS Solution Gains Momentum Within the Life Science Vertical

7 of the top 20 Pharmaceutical companies are customers of Revvy Global Price Management, a SaaS solution to manage prices globally Redwood City, CA – March 2, 2015 – Model N, Inc. (NYSE: [...]

revvygpm7 of the top 20 Pharmaceutical companies are customers of Revvy Global Price Management, a SaaS solution to manage prices globally

Redwood City, CA – March 2, 2015 – Model N, Inc. (NYSE: MODN), the leading revenue management solutions provider to the life science and technology industries, today announced that 7 of the top 20 pharmaceutical companies, including Gilead, are customers of Revvy Global Price Management (GPM), a Software-as-a-Service (SaaS) solution to drive effective global pricing strategies.

With the recent addition of a Top 3 Pharmaceutical company to the roster, Revvy GPM customers represent over 2,000 seats in over 100 countries, supporting product portfolios that collectively generate over $100B in revenue.

Maximizing revenues and reducing price erosion is top of mind for Pharmaceutical executives and requires access to up-to-date global pricing data, improving cross-regional pricing collaboration and uncovering insights through historical and predictive analytics. Failing to manage and understand pricing on a global level can translate into revenue loss amounting to tens of millions of dollars. International Reference Pricing adds another layer of complexity. A price change in one country can dramatically lower the prices that government buyers are willing to pay in other countries, creating a geo-complexity for the Pharmaceutical CFO and can result in millions of dollars of annual losses and negative brand equity.

Model N Revvy Global Price Management (GPM) is the only enterprise-grade SaaS solution for the life science vertical focused on helping pharmaceutical, biopharmaceutical, and medical device companies maximize revenues by reducing price erosion and comply with global pricing regulations.

Built for international pricing and market access department leaders, the solution helps global pricing teams realize better prices throughout the product lifecycle, surfacing insights to execute revenue maximizing pricing strategies, and drive better business governance with unified pricing processes. It is the only global pricing, vertical specific, SaaS solution built on the Salesforce1 Platform that delivers enterprise-grade business continuity, collaboration, efficiency and work process flexibility.

“The life science industry continues to require an end-to-end, enterprise class solution to manage timely global pricing” said Zack Rinat, Founder, Chairman and Chief Executive Officer at Model N. “With pressures on price such as international referencing becoming more and more common both at launch and on an on-going basis, Global Price Management becomes a strategic imperative.”

About Model N’s Revvy Global Price Management

Revvy Global Price Management helps global manufacturers mitigate reference pricing risk and profitability erosion through a powerful combination of data management, SaaS applications, and best practices, including:

  • Global Pricing Database: Manage price lists, calendar of price events, fix rates, volume forecasts in a single global repository
  • Global Price Governance: Administer user roles and rights; manage approval routes; trigger alerts, acknowledgement or escalation
  • Rule Definitions and Calculations: Consolidate international reference pricing (IRP) rules — country baskets, formulas, timing, channel, formal/informal, etc.
  • Simulation Analytics and Reporting: Access price change impact reports and referencing country reports, create ad-hoc reports and charts
  • Launch Tracking and Optimization: Monitor launch preparedness and market access timelines, and identify best combinations of launch date and price in each country
  • Cloud Delivery and Mobile Access: Optimize time to value and reduce capital outlays through rapid cloud deployment; built on the force.com platform. Mobile application for on-the-go data access and price request approvals
About Model N

Model N is the leader in Revenue Management Cloud solutions. Model N helps its customers maximize their revenues by maximizing sell time, revenues per opportunity and number of opportunities. Model N Cloud solutions manage every dollar that impacts the customer’s top line and transforms the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the unique business needs of life science and technology companies across more than 100 countries. Global customers include: Actavis, Allergan, Atmel, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: http://www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.

Legal

Model N® is a registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

Additional Resources

White Paper: Define a Global Price Management and Market Access Strategy
Gilead and Model N Webinar: Effectiveness in Global, Regional and Market pricing
Website: Revvy Global Price Management

Infographic: International Reference Pricing 

Connect with Model N

LinkedIn

Twitter (@ModelN)

Facebook

Google+

Media Contact

Sara Black

Grayling

Tel: 213.618.1501

Email: sara.black@grayling.com

Model N Continues to Shape Revenue Management Thought Leadership at Upcoming Pharma Pricing & Market Access Congress 2015

GENEVA, CH – February 24, 2015 – Model N, Inc. (NYSE: MODN), the leading revenue management solutions provider to the life science and technology industries, announced today another contribution [...]

pharmapricingGENEVA, CH – February 24, 2015 – Model N, Inc. (NYSE: MODN), the leading revenue management solutions provider to the life science and technology industries, announced today another contribution to its thought leadership initiatives in the life sciences sector, by sponsoring the Pharma Pricing & Market Access Congress 2015 on February 24-26 in London. Model N will be located at Booth 6 at  the world’s largest Pharma Market Access Congress.

James Robinson, Director of Industry Solutions for Europe at Model N, will share his expertise at the first conference day in his speech “Global prize optimization made easy” (February 24, 2pm). The long experienced specialist for pricing and profitability management in the pharma sector will elaborate on how increasingly sophisticated payer tactics are upping the ante for pricing teams striving to optimize local access versus global returns on investment.

“Higher risks of price leakage in combination with a higher demand from executive management for insights and options are creating an acute focus on pricing decisions”, explains Robinson. “Pharma companies are shifting to align global governance and organizations while enabling local autonomic execution.”

Due to the dynamic evolution of the pricing space, continuous innovation in this field is becoming a strategic focus for pricing teams in the pharmaceutical industry. Model N is a thought leader in pricing and profit optimization and leads the way by innovating together with its customers, including Gilead and Janssen Pharmaceuticals and others.

In close collaboration with its customers, Model N is providing new advanced functionalities with every product release, which allows pharma companies to make better decisions, maximize their revenues and margins and enables effective global pricing strategies.

The Pharma Pricing and Market Access Congress 2015

Europe’s most respected market access and pricing conference brings together more than 200 attendees and 40 top speakers out of 15 countries, to benchmark their strategic decision making in pricing. The event will share the latest developments across the globe with insights from key payers and pharma companies. Participants can learn how to prepare their market access strategy for the ever changing global healthcare market and understand the diverse payer landscape and how to inform decision making with insight from key payer organizations. In addition, the providers of the latest industry solutions and technologies illustrate how they can benefit enterprises in pricing decisions. For more information on the upcoming Pricing & Market Access Congress 2015 or to register, please visit:

http://www.healthnetworkcommunications.com/conference/pharma-pricing/

About Model N

Model N is the leader in Revenue Management Cloud solutions. Model N helps its customers maximize their revenues by maximizing sell time, revenues per opportunity and number of opportunities. Model N Cloud solutions manage every dollar that impacts the customer’s top line and transforms the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the unique business needs of life science and technology companies across more than 100 countries. Global customers include: Actavis, Allergan, Atmel, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: http://www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.

Legal

Model N® is a registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

Connect with Model N

LinkedIn

Twitter (@ModelN)

Facebook

Google+

Media Contact

Jan Leder

Grayling

Tel: (+49) (0)211.9648.541

Email: jan.leder@grayling.com

Model N Recognizes Revenue Management Leaders from Life Science and Technology Companies

Leading Companies Recognized at Rainmaker 2015 Conference for their Achievements with Revenue Management SAN FRANCISCO, CA – February 12, 2015 – Model N, Inc. (NYSE: MODN), the leader in Revenue [...]

15840183583_f5432ca91b_oLeading Companies Recognized at Rainmaker 2015 Conference for their Achievements with Revenue Management

SAN FRANCISCO, CA – February 12, 2015 – Model N, Inc. (NYSE: MODN), the leader in Revenue Management solutions, announced the recipients of the Rainmaker Awards at Rainmaker 2015 in San Francisco. Each year, Model N recognizes companies that have driven tremendous results by transforming their business processes through vision, analytics, best practices, innovation, passion and globalization of Revenue Management.

“I would like to congratulate the recipients of this year’s Revenue Management Leader awards for their passion, determination and commitment to excellence.” said Zack Rinat, Founder, Chairman and Chief Executive Officer of Model N. “We are proud to recognize these life science and high tech visionaries for their impressive achievements.”

The recipients of the 2015 Rainmaker awards are:

AstraZeneca: Revenue Management Globalization

This award recognizes a company who has set a vision and strategy of Global Revenue Management and has executed well to bring this vision to reality.

Johnson & Johnson: Revenue Management Innovator

This award recognizes a company who has made significant innovation in Revenue Management.

Actavis: Revenue Management Visionary

This award recognizes a company that has expanded the horizons of Revenue Management.

Celgene: Revenue Management Best Practice

This award recognizes a company that has excelled implementing Revenue Management system achieving on-time, on–budget and on-value for the project,

EMD Serono: Revenue Management Analytics

This award recognizes a company that deployed and leveraged Revenue Intelligence Cloud to drive revenues.

Linear Technology: Revenue Management Passion for the Journey

This award recognizes a company that believes that Revenue Management is a journey, not a destination and has demonstrated an abundant passion for that journey over an extended period of time.

The Rainmaker Awards were presented this year at AT&T Park, home of the 2014 World Series Champions, the San Francisco Giants.

About Model N

Model N is the leader in Revenue Management Cloud solutions. Model N helps its customers maximize their revenues by maximizing sell time, revenues per opportunity and number of opportunities. Model N Cloud solutions manage every dollar that impacts the customer’s top line and transforms the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the unique business needs of life science and technology companies across more than 100 countries. Global customers include: Actavis, Allergan, Atmel, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: http://www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.

Legal

Model N® is a registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

Connect with Model N

LinkedIn

Twitter (@ModelN)

Facebook

Google+

Media Contact

Sara Black

Grayling

Tel: 213.618.1501

Email: sara.black@grayling.com

Model N Kicks Off Rainmaker 2015, Unveils New Revenue Management Cloud Tools, CFO Survey Findings

Adobe CFO, Mark Garrett and Three-Time Super Bowl Champion Roger Craig to Present Keynotes at Conference Focused on Revenue Management Cloud for Fortune 500 Companies SAN FRANCISCO, CA – February [...]

rainmakerAdobe CFO, Mark Garrett and Three-Time Super Bowl Champion Roger Craig to Present Keynotes at Conference Focused on Revenue Management Cloud for Fortune 500 Companies

SAN FRANCISCO, CA – February 3rd, 2015 – Model N, Inc. (NYSE: MODN), the leading Revenue Management solutions provider to the life science and technology industries, today kicked off Rainmaker 2015, the only industry conference dedicated to Revenue Management, in San Francisco. Model N unveiled its vision for the future of Revenue Management, introduced Revenue Management as a Service and Revenue Management Cloud and revealed the results of its CFO survey during the annual conference.

Held at the Westin St. Francis hotel in downtown San Francisco from Feb. 3-4, this year’s Rainmaker conference breaks the record with attendance of over 300 attendees including industry experts from the life science and technology industries to collaborate and share insights on mission critical aspects of Revenue Management.

“On our 11th Rainmaker, we are excited to have record attendance this year with the theme of Revenue Champions. Our customers and partners comprise of the world’s leading global brands and are championing Revenue Management — a mission critical solution, within their organizations,” said Zack Rinat, Founder, Chairman and Chief Executive Officer of Model N. “Rainmaker is the fountainhead of the latest and greatest in Revenue Management Cloud offerings, and I want to thank our customers and sponsors in making this happen.”

With this year’s theme and venue in the City of Champions, Model N celebrates its customer awards at the AT&T Park, home of the 2014 World Series Champions, the SF Giants. This event brings together a collection of champions including keynotes from NFL champion and 49ers Hall of Fame running back Roger Craig and Executive Vice President and Chief Financial Officer of Adobe Mark Garrett as well as executives from saleforce.com.

Key Announcements

Model N announced the launch of its Winter ’14 Revenue Management Cloud product with multiple go-lives in record time, Revvy Sales on the AppExchange and Revenue Management as a Service.

RMaaS is a three-step strategy that provides no-hassle upgrades, reduces total cost of ownership, accelerates time to value and eliminates financial risk for Model N customers. It builds on key benefits such as accelerated migration, configurable architecture, customer-specific testing and automation, monitoring & support and on-boarding and training.

Model N CFO Survey: Apple CFO is the Most Admired of Top Fortune 500 Companies

Model N announced the results of its CFO survey of 300 executives within the U.S. revealing that Apple’s Chief Financial Officer Luca Maestri is the most admired CFO from the Fortune 500, with 94% of executives surveyed asserting that the CFO is one of the most important positions for companies today.

When looking at Revenue Management — a strategic approach to managing every dollar that impacts the top-line of the business — nearly all executives surveyed (95%) believe it is critical to the growth and success of the company and agreed that it’s critical for CFOs to be included in the sales cycle. However, nearly three-quarters (74%) of executives surveyed admitted that their CFO is not currently involved in the sales conversation because he or she has no direct experience leading a sales organization.

For registration and additional information, please visit the Rainmaker 2015 website.

About Model N

Model N is the leader in Revenue Management Cloud solutions. Model N helps its customers maximize their revenues by maximizing sell time, revenues per opportunity and number of opportunities. Model N Cloud solutions manage every dollar that impacts the customer’s top line and transforms the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the unique business needs of life science and technology companies across more than 100 countries. Global customers include: Actavis, Allergan, Atmel, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: http://www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.

Legal

Model N® is a registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

Connect with Model N

LinkedIn

Twitter (@ModelN)

Facebook

Google+

Contact

Sara Black

Grayling

Tel: 213.618.1501

Email: sara.black@grayling.com

Model N Revenue Management Survey: Apple’s CFO Luca Maestri is Most Admired Fortune 500 CFO

Compelling CFO Findings on Revenue Management, Including CFO Involvement in Sales Cycles SAN FRANCISCO, CA – February 3rd, 2015 – Model N, Inc. (NYSE: MODN), the leading Revenue Management [...]

luccamaestriCompelling CFO Findings on Revenue Management, Including CFO Involvement in Sales Cycles

SAN FRANCISCO, CA – February 3rd, 2015 – Model N, Inc. (NYSE: MODN), the leading Revenue Management solutions provider to the life science and technology industries, today announced the results of its CFO Revenue Management Study, which revealed that Apple’s Chief Financial Officer Luca Maestri is the most admired CFO from the Fortune 500. Nearly one in four (24%) executives identified Luca Maestri, followed by Walmart CFO Charles Holley (15%) and Ford CFO Bob Shanks (8%). Over half of the respondents (55%) cited the company’s performance as the primary reason for nominating the CFO.

Model N surveyed sales and C-level executives from across the country to determine industry perspectives on revenue management and to uncover the role CFOs can play in driving sales and company growth. Nearly all (94%) executives surveyed said that the CFO is one of the most important positions for companies today, with more than half (54%) saying this is because managing financial risks of the corporation is more important than ever before and more than a quarter (26%) stating that companies today need a C-level executive focused on Revenue Management.

Nearly all executives surveyed (95%) said that Revenue Management — an end-to-end strategic approach of managing every dollar that impacts the top-line of the business — is critical to the growth and success of the company and agreed that it’s critical for CFOs to be included in the sales cycle. However, nearly three-quarters (74%) of executives surveyed admitted that their CFO is not currently involved in the sales conversation because he or she has no direct experience leading a sales organization (35%) or is unfamiliar with a standard set of metrics for evaluating sales and marketing performance (23%). One in five executives said their CFO is not currently involved in sales because no solution exists to help him or her understand it.

“CFOs are uniquely positioned to drive growth and to help ensure that investments in sales are contributing to the profitability of the company,” said Shail Khiyara, SVP and Chief Marketing Officer of Model N. “Outdated spreadsheets, inefficient legacy business processes and lack of visibility leads to price erosion, revenue leakage, and impacts growth. Revenue Management Cloud solutions are the force multiplier that CFOs are seeking to drive visibility into every dollar that touches the top-line of their income statement.”

Model N is the leader in delivering Revenue Management Cloud solutions to a top tier roster of life science and technology companies across more than 100 countries. The company pioneered the integration of revenue management solutions with CRM, cited as a strategic imperative to drive competitive advantage for companies seeking to grow their revenues in complex global ecosystems and help CFOs and sales teams make informed decisions.

Survey Methodology

Sample for this project consisted of a random selection of Innovate’s U.S. panelists including sales and C-level executives at companies across the country. Fielding period was from December 8-10, 2014 with more than 300 professionals providing their informed feedback.

About Model N

Model N is the leader in Revenue Management Cloud solutions. Model N helps its customers maximize their revenues by maximizing sell time, revenues per opportunity and number of opportunities. Model N Cloud solutions manage every dollar that impacts the customer’s top line and transforms the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the unique business needs of life science and technology companies across more than 100 countries. Global customers include: Actavis, Allergan, Atmel, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: http://www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.

Legal

Model N® is a registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

Connect with Model N

LinkedIn

Twitter (@ModelN)

Facebook

Google+

Contact

Sara Black

Grayling

Tel: 213.618.1501

Email: sara.black@grayling.com

Model N to Sponsor and Keynote Government Pricing Conference

REDWOOD CITY, CA – January 29th, 2015 – Model N, Inc. (NYSE: MODN), the leading Revenue Management solutions provider to the life science and technology industries, announced today that it will [...]

gdpREDWOOD CITY, CA – January 29th, 2015 – Model N, Inc. (NYSE: MODN), the leading Revenue Management solutions provider to the life science and technology industries, announced today that it will be sponsoring The Conference Forum’s Government Drug Pricing Forum February 11-13, 2015 in Washington, D.C.

Jesse Mendelsohn, Director at the Center of Excellence at Model N, will lead a keynote panel discussion on Feb. 12 on “Government Pricing 2020: The Government as a Customer” and will be joined by John Shakow, Partner at King & Spalding, LLC and Anne Dessertine, Partner at Lincoln Consulting.

The keynote session will delve into the government’s role as a customer for pharmaceutical companies, discuss how the landscape is evolving and what that means for profits, staffing, and compliance risks once the ACA and other recent legislation are fully implemented and in practice for several years.

Over 60 percent of pharmaceutical executives perceive regulatory and legislative issues to be the “most significant barrier to their company’s growth,” according to a study conducted by KPMG that surveyed 107 senior pharmaceutical executives, with 45 percent of respondents working at companies with annual revenues over $10 billion.

“Pharmaceutical companies need to anticipate how the US government’s role as a customer will drive pharmaceutical sales in the next five years and how government policy will impact commercial margins and commercial sales practices,” said Arnaud Grunwald, Chief Industry Executive for Life Sciences at Model N. “Our Regulatory Update Program ensures that Life Sciences customers are always current on government compliance and latest developments.”

With the Average Manufacturer Price (AMP) ruling around the corner in the first half of 2015, Shakow and Dessertine will advise the audience on other regulatory changes that the government may impose on pharmaceutical manufacturers over the next five years and will discuss techniques that manufacturers can adopt to stay informed, prepare and provide input to proposals being discussed on the Hill.

About Model N

Model N is the leader in Revenue Management Cloud solutions. Model N helps its customers maximize their revenues by maximizing sell time, revenues per opportunity and number of opportunities. Model N Cloud solutions manage every dollar that impacts the customer’s top line and transforms the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the unique business needs of life science and technology companies across more than 100 countries. Global customers include: Actavis, Allergan, Atmel, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: http://www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.

Legal

Model N® is a registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

Connect with Model N

LinkedIn

Twitter (@ModelN)

Facebook

Google+

Contact

Sara Black

Grayling

Tel: 213.618.1501

Email: sara.black@grayling.com

page 1 of 2